A review of -multidrug-resistant Enterobacteriaceae in a neonatal unit in Johannesburg, South Africa.


Journal

BMC pediatrics
ISSN: 1471-2431
Titre abrégé: BMC Pediatr
Pays: England
ID NLM: 100967804

Informations de publication

Date de publication:
07 09 2019
Historique:
received: 25 07 2018
accepted: 03 09 2019
entrez: 9 9 2019
pubmed: 9 9 2019
medline: 15 12 2020
Statut: epublish

Résumé

Multi-drug resistant organisms are an increasingly important cause of neonatal sepsis. This study aimed to review neonatal sepsis caused by multi-drug resistant Enterobacteriaceae (MDRE) in neonates in Johannesburg, South Africa. This was a cross sectional retrospective review of MDRE in neonates admitted to a tertiary neonatal unit between 1 January 2013 and 31 December 2015. There were 465 infections in 291 neonates. 68.6% were very low birth weight (< 1500 g). The median age of infection was 14.0 days. Risk factors for MDRE included prematurity (p = 0.01), lower birth weight (p = 0.04), maternal HIV infection (p = 0.02) and oxygen on day 28 (p < 0.001). The most common isolate was Klebsiella pneumoniae (66.2%). Total MDRE isolates increased from 0.39 per 1000 neonatal admissions in 2013 to 1.4 per 1000 neonatal admissions in 2015 (p < 0.001). There was an increase in carbapenem-resistant Enterobacteriaceae (CRE) from 2.6% in 2013 to 8.9% in 2015 (p = 0.06). Most of the CRE were New Delhi metallo-β lactamase- (NDM) producers. The all-cause mortality rate was 33.3%. Birth weight (p = 0.003), necrotising enterocolitis (p < 0.001) and mechanical ventilation (p = 0.007) were significantly associated with mortality. Serratia marcescens was isolated in 55.2% of neonates that died. There was a significant increase in MDRE in neonatal sepsis during the study period, with the emergence of CRE. This confirms the urgent need to intensify antimicrobial stewardship efforts and address infection control and prevention in neonatal units in LMICs. Overuse of broad- spectrum antibiotics should be prevented.

Sections du résumé

BACKGROUND
Multi-drug resistant organisms are an increasingly important cause of neonatal sepsis.
AIM
This study aimed to review neonatal sepsis caused by multi-drug resistant Enterobacteriaceae (MDRE) in neonates in Johannesburg, South Africa.
METHODS
This was a cross sectional retrospective review of MDRE in neonates admitted to a tertiary neonatal unit between 1 January 2013 and 31 December 2015.
RESULTS
There were 465 infections in 291 neonates. 68.6% were very low birth weight (< 1500 g). The median age of infection was 14.0 days. Risk factors for MDRE included prematurity (p = 0.01), lower birth weight (p = 0.04), maternal HIV infection (p = 0.02) and oxygen on day 28 (p < 0.001). The most common isolate was Klebsiella pneumoniae (66.2%). Total MDRE isolates increased from 0.39 per 1000 neonatal admissions in 2013 to 1.4 per 1000 neonatal admissions in 2015 (p < 0.001). There was an increase in carbapenem-resistant Enterobacteriaceae (CRE) from 2.6% in 2013 to 8.9% in 2015 (p = 0.06). Most of the CRE were New Delhi metallo-β lactamase- (NDM) producers. The all-cause mortality rate was 33.3%. Birth weight (p = 0.003), necrotising enterocolitis (p < 0.001) and mechanical ventilation (p = 0.007) were significantly associated with mortality. Serratia marcescens was isolated in 55.2% of neonates that died.
CONCLUSIONS
There was a significant increase in MDRE in neonatal sepsis during the study period, with the emergence of CRE. This confirms the urgent need to intensify antimicrobial stewardship efforts and address infection control and prevention in neonatal units in LMICs. Overuse of broad- spectrum antibiotics should be prevented.

Identifiants

pubmed: 31493789
doi: 10.1186/s12887-019-1709-y
pii: 10.1186/s12887-019-1709-y
pmc: PMC6731552
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

320

Références

Pediatrics. 2002 Aug;110(2 Pt 1):285-91
pubmed: 12165580
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Clin Microbiol Infect. 2012 Mar;18(3):268-81
pubmed: 21793988
J Clin Microbiol. 2012 Feb;50(2):525-7
pubmed: 22116157
Diagn Microbiol Infect Dis. 2012 Jul;73(3):290-1
pubmed: 22521054
S Afr Med J. 2012 May 10;102(7):599-601
pubmed: 22748433
ISRN Pediatr. 2012;2012:508512
pubmed: 22919509
Int J Infect Dis. 2013 Nov;17(11):e961-5
pubmed: 23759260
Pharmaceuticals (Basel). 2013 Nov 01;6(11):1335-46
pubmed: 24287460
Pediatrics. 2014 Feb;133(2):e322-9
pubmed: 24420803
PLoS One. 2014 Nov 18;9(11):e112101
pubmed: 25406074
Clin Infect Dis. 2015 May 1;60(9):1389-97
pubmed: 25595742
J Trop Pediatr. 2015 Feb;61(1):1-13
pubmed: 25604489
Paediatr Int Child Health. 2015 Aug;35(3):265-72
pubmed: 25940506
Braz J Infect Dis. 2016 Mar-Apr;20(2):134-40
pubmed: 26867474
BMC Infect Dis. 2016 Jul 11;16:326
pubmed: 27400864
S Afr Med J. 2016 Aug 18;106(9):877-82
pubmed: 27601110
Pathog Glob Health. 2016 Sep;110(6):238-246
pubmed: 27650884
Int J Microbiol. 2017;2017:8486742
pubmed: 28250772
Curr Opin Infect Dis. 2017 Jun;30(3):281-288
pubmed: 28306563
J Hosp Infect. 2017 Jun;96(2):130-131
pubmed: 28433397
Pediatr Neonatol. 2018 Feb;59(1):35-41
pubmed: 28642139
F1000Res. 2017 Jul 25;6:1217
pubmed: 28781766
Nutrients. 2017 Aug 22;9(8):null
pubmed: 28829405
Ann Surg. 1978 Jan;187(1):1-7
pubmed: 413500

Auteurs

Daynia E Ballot (DE)

Neonatal Unit, Department of Paediatrics and Child Health, University of the Witwatersrand and Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, South Africa. daynia.ballot@wits.ac.za.
Infection control, Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, 2196, South Africa. daynia.ballot@wits.ac.za.

Rosella Bandini (R)

Critical Care Infection Collaboration, Witwatersrand, South Africa.

Trusha Nana (T)

Department of Clinical Microbiology and Infectious Diseases, School of Pathology of the National Health Laboratory Services and University of Witwatersrand, Witwatersrand, South Africa.

Noma Bosman (N)

Department of Clinical Microbiology and Infectious Diseases, School of Pathology of the National Health Laboratory Services and University of Witwatersrand, Witwatersrand, South Africa.

Teena Thomas (T)

Department of Clinical Microbiology and Infectious Diseases, School of Pathology of the National Health Laboratory Services and University of Witwatersrand, Witwatersrand, South Africa.

Victor A Davies (VA)

Neonatal Unit, Department of Paediatrics and Child Health, University of the Witwatersrand and Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, South Africa.

Peter A Cooper (PA)

Neonatal Unit, Department of Paediatrics and Child Health, University of the Witwatersrand and Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, South Africa.

Mervyn Mer (M)

Infection control, Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, 2196, South Africa.
Department of Critical Care, University of the Witwatersrand, Witwatersrand, South Africa.

Jeffrey Lipman (J)

Infection control, Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, 2196, South Africa.
The University of Queensland, Brisbane, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH